Rare diseases
Investigational molecules
Locations
Ul. Kosynierow Gdynskich 61, 93-357 Lodz, Poland
Bonifraterskie Centrum Medyczne Sp. z o.o. in Lodz, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Erosive oesophagitis, Gastrooesophageal reflux disease, Crohn's disease, and other specialisations. This site conducts important research.
At Bonifraterskie Centrum Medyczne Sp. z o.o. in Lodz, clinical research in digestive system diseases focuses mainly on ulcerative colitis, Crohn’s disease, and erosive esophagitis linked to gastroesophageal reflux disease. These studies are designed to assess how well new treatments can bring symptoms under control, improve healing, and support longer-term disease management.
The site’s Endoscopy Department is part of this work, supporting research that aims to improve care for people with chronic gastrointestinal conditions.
Research in eye diseases at this hospital includes studies in atrophic age-related macular degeneration, a condition that can gradually affect central vision. The main goal is to evaluate whether new therapies may help slow disease progression and preserve sight.
This area of research reflects a broader effort to improve options for people living with chronic retinal disease.
Clinical trials in immune system phenomena at Szpital Zakonu Bonifratrów św. Jana Bożego w Łodzi are closely connected to ulcerative colitis and related inflammatory bowel disease. These studies explore whether newer immune-targeted treatments can help patients achieve remission and maintain better disease control over time.
The research combines symptom relief goals with careful attention to treatment safety and durability.
Studies in ocular physiological phenomena focus on how new treatments may affect the structure and function of the eye in atrophic AMD. The emphasis is on understanding whether investigational therapies can help protect retinal health and improve outcomes for patients with progressive vision loss.
These trials support a more detailed understanding of eye function in degenerative retinal conditions.
Clinical trials currently enrolling participants at this site.
Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
PolandLong-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis
PolandNHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
PolandStudy of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy
PolandStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
PolandComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
PolandStudy of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis
PolandStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
PolandA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
PolandStudy on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
